0.295
-0.08 (-20.96%)
| Penutupan Terdahulu | 0.373 |
| Buka | 0.316 |
| Jumlah Dagangan | 6,031,474 |
| Purata Dagangan (3B) | 9,519,429 |
| Modal Pasaran | 10,356,502 |
| Harga / Jualan (P/S) | 6.53 |
| Harga / Buku (P/B) | 0.130 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -383.28% |
| EPS Cair (TTM) | -0.540 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -16.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -30.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.61% |
| Nisbah Semasa (MRQ) | 0.250 |
| Aliran Tunai Operasi (OCF TTM) | -1.75 M |
| Pulangan Atas Aset (ROA TTM) | -11.32% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | OSR Health, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.13 |
|
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 62.40% |
| % Dimiliki oleh Institusi | 0.35% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |